Coronary intervention for stable angina
- PMID: 30591431
- DOI: 10.1136/bmj.k5351
Coronary intervention for stable angina
Conflict of interest statement
Competing interests: The BMJ has judged that there are no disqualifying financial ties to commercial companies. The authors declare the following other interests: AT was a member of the data monitoring committee for the DEVOTE trial evaluating a long acting insulin for diabetes. He received travel expenses from Novo Nordisk to attend a presentation of trial findings at the 2017 European Society of Cardiology annual congress.
Comment on
-
Percutaneous coronary intervention in stable angina (ORBITA): a double-blind, randomised controlled trial.Lancet. 2018 Jan 6;391(10115):31-40. doi: 10.1016/S0140-6736(17)32714-9. Epub 2017 Nov 2. Lancet. 2018. PMID: 29103656 Clinical Trial.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical